browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
125765fc-df56-433f-bd28-e6ae08da30dd
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:52:50
Income (reported)
—
Expenses (reported)
$2,080,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

ABBVIE, INC.

Biopharmaceutical company

Contact
DANIEL BACHNER
Phone
+1 202-383-9616
Address
zip:20005, city:Washington, state:DC, street:1399 New York Avenue NW Suite 600
Client

ABBVIE INC.

State
DC
Country
US
Government-entity client
false
Effective date
2013-02-25
Issues lobbied + lobbyists (6)

HCR — Health Issues

S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to Hepatitis C elimination Issues related to FDA communications

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

TRD — Trade (domestic/foreign)

Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China

Lobbyists:

Government entities lobbied: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.